Synlogic Inc SYBX

NAS: SYBX | ISIN: US87166L1008 14/11/2024

1,390 USD (-1,42%)

(-1,42%) 14/11/2024

Grafiek Synlogic Inc

Grafiek Synlogic Inc

1 dag1d -1,42%
1 week1w -3,91%
1 maand1m -1,42%
3 maanden3m -2,11%
6 maanden6m -19,19%
1 jaar1j -33,81%
5 jaar5j -33,81%

Synlogic Inc in het nieuws

Toon enkel gratis nieuws

11 augustus 2022 · Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks · Persbericht

23 november 2021 · Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 · Persbericht

10 november 2021 · Synlogic Reports Third Quarter Financial Results and Provides Business Update · Persbericht

10 november 2021 · Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting · Persbericht

9 november 2021 · Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria · Persbericht

2 november 2021 · Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference · Persbericht

28 oktober 2021 · Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria · Persbericht

15 oktober 2021 · Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 · Persbericht

12 oktober 2021 · Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform · Persbericht

27 september 2021 · Synlogic Appoints Molly Harper as Chief Business Officer · Persbericht

Profiel Synlogic Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.synlogictx.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

CEO: Aoife Brennan

Werknemers: 107

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe